Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Ganguly 2022 BEC

From Bioblast


Bioenergetics Communications        
Gnaiger 2020 BEC MitoPathways
       
Gnaiger Erich et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1.
        MitoPedia: BEC         MitoPedia: Gentle Science         MitoFit Preprints         DOI Data Center
Bioenergetics Communications
Publications in the MiPMap
Ganguly U, Bir A, Chakrabarti S (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. Bioenerg Commun 2022.14. https://doi.org/10.26124/bec:2022-0014

» Bioenerg Commun 2022.14. Open Access pdf
published online 2022-11-22

Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka (2022) Bioenerg Commun

Abstract: BEC.png https://doi.org/10.26124/bec:2022-0014

Graphical abstract

Ferroptosis, a type of regulated cell death, has been implicated in various diseases like cancer and neurodegenerative diseases including Parkinson’s disease. Because the mitochondrial Complex I inhibitor rotenone is widely used to develop experimental models of Parkinson’s disease, we examined if rotenone is an inducer of ferroptosis. Ferroptosis is iron-dependent and accompanied by increased production and accumulation of reactive oxygen and nitrogen species and lipid oxidation products, depletion of reduced glutathione, mitochondrial morphological alterations, and rupture of the plasma membrane. The mechanism of cell death in ferroptosis subsequent to the accumulation of ROS and lipid oxidation products, however, is not clearly established. We show here that rotenone (0.5 µM) causes the death of SH-SY5Y cells (a human neuroblastoma cell line) within 48 h accompanied by mitochondrial membrane depolarization, intracellular ATP depletion, increased production and accumulation of ROS and the lipid oxidation product malondialdehyde and a decrease in reduced glutathione content. These processes are inhibited conspicuously by novel inhibitors of ferroptosis such as ferrostatin-1 and liproxstatin-1 without rescuing the rotenone-induced inhibition of Complex I activity. Further, after rotenone-treatment both apoptotic and necrotic cells were noticed as evidenced from nuclear morphology after staining by Hoechst 33258 and propidium iodide, respectively. Taken together, rotenone was an inducer of ferroptosis in SH-SY5Y cells which presented morphological features of apoptosis and necrosis.

Keywords: rotenone, mitochondria, ferroptosis, reactive oxygen and nitrogen species, neurodegeneration Bioblast editor: Tindle-Solomon L O2k-Network Lab: IN Haldia Chakrabarti S

ORCID: ORCID.png Ganguly Upasana, ORCID.png Bir Aritri, ORCID.png Chakrabarti Sasanka

MitoFit Preprint

» Ganguly 2022 MitoFit


Labels: Pathology: Parkinson's  Stress:Cell death, Oxidative stress;RONS 

Tissue;cell: Nervous system, Neuroblastoma 

Enzyme: Complex I, Complex III  Regulation: ATP production, Inhibitor, mt-Membrane potential 



BEC